982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)

• Geoffrey I Shapiro,
• Anita Mehta,
• Jennifer L Guerriero,
• Adam Nelson,
• Patrice A Lee,
• Madisson Oliwa,
• Filipa Lynce,
• Nabihah Tayob,
• Madeline G Townsend,
• Kelly F Zheng,
• Nicholas A Saccomano

Affiliations

Geoffrey I Shapiro

13Dana-Farber Cancer Institute, Medical Oncology, Boston, USA

Anita Mehta

1Dana Farber Cancer Institute, Boston, MA, USA

Jennifer L Guerriero

6 Division of Breast Surgery, Department of Surgery, Brigham and Women`s Hospital, Boston, Massachusetts, USA

Adam Nelson

2Harvard Medical School, Boston, MA, USA

Patrice A Lee

Department of Pharmacology and Toxicology, Array BioPharma Inc., Boulder, Colorado, USA

Madisson Oliwa

1Brigham and Women’s Hospital, Boston, MA, USA

Filipa Lynce

3Dana-Farber Cancer Institute, Boston, MA, USA

Nabihah Tayob

2 Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Madeline G Townsend

1Brigham and Woman’s Hospital, Boston, MA, USA

Kelly F Zheng

1Brigham and Woman’s Hospital, Boston, MA, USA

Nicholas A Saccomano

4Pfizer, Boulder, CO, USA